Jump to content

Verrucarin A

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by AnomieBOT (talk | contribs) at 19:18, 21 August 2022 (Dating maintenance tags: {{Cn}}). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Verrucarin A
Names
Other names
Muconomycin A
Identifiers
ECHA InfoCard 100.164.324 Edit this at Wikidata
Properties
C27H34O9
Molar mass 502.560 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Verrucarin A is a chemical compound that belongs in the class of trichothecenes, a group of sesquiterpene toxins produced by several fungi, namely from the Fusarium species, that are responsible for infecting food grains. Within the skeleton of the basic trichothecene structure, the olefin and epoxide are crucial for toxicity; ester functionalities and hydroxyl groups often contribute to the toxicity, thereby rendering verrucarin A as one of the most lethal examples.[citation needed] The mechanism of action for this class of toxins mainly inhibits protein biosynthesis by preventing peptidyl transferase activity. Although initially thought to be potentially useful as anticancer therapeutics, numerous examples of trichothecene derivatives were shown to be too toxic for clinical use.

Biosynthesis

Verrucarin A is classified as a type D trichothecene based on its substitution pattern in the 12,13-epoxytrichothec-9-ene (EPT) core structure. Type D differs from types A, B and C by containing an additional ring linking the C-4 and C-15 position. Trichothecenes are generally formed via the mevalonate pathway beginning with the precursor farnesyl pyrophosphate (FPP).[1] After cyclization of FPP to form trichodiene, TRI4 encodes a cytochrome P450 enzyme to catalyze a series of oxygenation events. Upon the addition of three oxygens at C-2, C-11 and the C-12,13 epoxide, the intermediate isotrichodiol is formed. Isotrichodiol then isomerizes, yielding the tricothecane EPT core structure. Subsequently, it is proposed that a series of hydroxylations and acylations occur at C-15 and C-4 which then cyclize at these carbons.[2]

References

  1. ^ Dewick, Paul. Medical Natural Products: A Biosynthetic Approach, 3rd edition. John Wiley & Sons Ltd. pp. 187–310. ISBN 9780470742761.
  2. ^ McCormick, Susan; Stanley, April; Stover, Nicholas; Alexander, Nancy (2011). "Trichothecenes: From Simple to Complex Mycotoxins". Toxins. 3 (7): 802–814. doi:10.3390/toxins3070802. PMC 3202860. PMID 22069741.